Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 2
2008 1
2012 1
2013 1
2018 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.
Thomas M, Rübe C, Hoffknecht P, Macha HN, Freitag L, Linder A, Willich N, Hamm M, Sybrecht GW, Ukena D, Deppermann KM, Dröge C, Riesenbeck D, Heinecke A, Sauerland C, Junker K, Berdel WE, Semik M; German Lung Cancer Cooperative Group. Thomas M, et al. Lancet Oncol. 2008 Jul;9(7):636-48. doi: 10.1016/S1470-2045(08)70156-6. Epub 2008 Jun 24. Lancet Oncol. 2008. PMID: 18583190 Clinical Trial.
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
Schumacher A, Riesenbeck D, Braunheim M, Wewers D, Heinecke A, Semik M, Hoffknecht P, Macha HN, Klinke F, Schmidt EW, Willich N, Berdel WE, Thomas M; German Lung Cancer Cooperative Group. Schumacher A, et al. Lung Cancer. 2004 Apr;44(1):89-97. doi: 10.1016/j.lungcan.2003.10.004. Lung Cancer. 2004. PMID: 15013587 Clinical Trial.
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients.
Ediebah DE, Coens C, Maringwa JT, Quinten C, Zikos E, Ringash J, King M, Gotay C, Flechtner HH, Schmucker von Koch J, Weis J, Smit EF, Köhne CH, Bottomley A; Gastro-Intestinal Tract Cancer Cooperative Group; Lung Cancer Cooperative Group; Quality of Life Department and Patient Reported Outcome and Behavioural Evidence (PROBE). Ediebah DE, et al. Ann Oncol. 2013 Jan;24(1):231-7. doi: 10.1093/annonc/mds220. Epub 2012 Aug 30. Ann Oncol. 2013. PMID: 22935549 Free PMC article. Clinical Trial.
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Mavroudis D, Papadakis E, Veslemes M, Tsiafaki X, Stavrakakis J, Kouroussis C, Kakolyris S, Bania E, Jordanoglou J, Agelidou M, Vlachonicolis J, Georgoulias V; Greek Lung Cancer Cooperative Group. Mavroudis D, et al. Ann Oncol. 2001 Apr;12(4):463-70. doi: 10.1023/a:1011131303391. Ann Oncol. 2001. PMID: 11398877 Free article. Clinical Trial.
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Scagliotti GV, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M; Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators. Scagliotti GV, et al. J Natl Cancer Inst. 2003 Oct 1;95(19):1453-61. doi: 10.1093/jnci/djg059. J Natl Cancer Inst. 2003. PMID: 14519751 Clinical Trial.
How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.
Zhang Y, Shen J, Simone CB 2nd, Cappuzzo F, Fong KM, Rosell R, Chang JY, Ampollini L, Choi JI, He J, Jiang T; Written on behalf of AME Lung Cancer Cooperative Group. Zhang Y, et al. J Thorac Dis. 2018 Jun;10(6):3883-3890. doi: 10.21037/jtd.2018.06.101. J Thorac Dis. 2018. PMID: 30069390 Free PMC article. No abstract available.